Treace Medical Concepts (TMCI) Amortizatization of Intangibles (2022 - 2026)
Treace Medical Concepts' (TMCI) quarterly Amortizatization of Intangibles came in at -$5000.0 in Q1 2026, down 106.49% YoY from $77000.0 in Q1 2025, and down 225.0% on a QoQ basis from $4000.0 in Q4 2025.
Treace Medical Concepts (TMCI) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends
Treace Medical Concepts (TMCI) has 5 years of Amortizatization of Intangibles data on file, last reported at -$5000.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles fell 106.49% year-over-year to -$5000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $41000.0 (down 95.38% YoY) and the FY2025 annual result came in at $123000.0, down 89.26% from the prior year.
- Amortizatization of Intangibles slipped to -$5000.0 in Q1 2026, from $4000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $375000.0 in Q4 2023 to a low of -$5000.0 in Q1 2026.
- A 5-year average of $199642.9 and a median of $230000.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2023 — Amortizatization of Intangibles soared 197.62% — and 2026, when it tumbled 106.49%.
- Tracing TMCI's Amortizatization of Intangibles over 5 years: stood at $126000.0 in 2022, then soared by 197.62% to $375000.0 in 2023, then plunged by 39.47% to $227000.0 in 2024, then tumbled by 98.24% to $4000.0 in 2025, then sank by 225.0% to -$5000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at -$5000.0 (Q1 2026), $4000.0 (Q4 2025), and $5000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 6.60 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | Treace Medical Concepts | 283.62 Mn | 238.00 Mn | 35.61 Mn | -6,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6,000.00 |
| Jun 30, 2026 | -6,000.00 |
| Mar 31, 2026 | -5,000.00 |
| Mar 31, 2026 | -5,000.00 |
| Dec 31, 2025 | 4,000.00 |
| Dec 31, 2025 | 4,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 37,000.00 |
| Jun 30, 2025 | 37,000.00 |
| Mar 31, 2025 | 77,000.00 |
| Mar 31, 2025 | 77,000.00 |
| Dec 31, 2024 | 227,000.00 |
| Dec 31, 2024 | 227,000.00 |
| Sep 30, 2024 | 233,000.00 |
| Sep 30, 2024 | 233,000.00 |
| Jun 30, 2024 | 350,000.00 |
| Jun 30, 2024 | 350,000.00 |
| Mar 31, 2024 | 335,000.00 |
| Mar 31, 2024 | 335,000.00 |